Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study Investigators

Lancet. 1998 May 30;351(9116):1657-8. doi: 10.1016/s0140-6736(05)77712-6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Anemia, Aplastic / chemically induced*
  • Anemia, Aplastic / epidemiology
  • Dose-Response Relationship, Drug
  • Female
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Neprilysin / antagonists & inhibitors*
  • Protease Inhibitors / administration & dosage
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / therapeutic use*
  • Thiorphan / administration & dosage
  • Thiorphan / adverse effects
  • Thiorphan / analogs & derivatives*
  • Thiorphan / therapeutic use

Substances

  • Protease Inhibitors
  • racecadotril
  • Thiorphan
  • Neprilysin